InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Akebia Therapeutics, Inc.

AKBA Clue Score38
United States Fiscal year ends December CIK 0001517022 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
John P. Butler
6 Aug 2026
CEO and President
Exercised, kept
350,000
$0.63
$220.50K
Erik Ostrowski
29 Jun 2026
SVP, CFO, CBO & Treasurer
Sold on a plan
56,019
$1.11
$62.18K
John P. Butler
4 Mar 2026
CEO and President
Buy
69,270
$1.25
$86.59K
John P. Butler
2 Feb 2026
CEO and President
Sold on a plan
83,689
$1.39
$116.33K
John P. Butler
2 Feb 2026
CEO and President
Sold on a plan
114,891
$1.39
$159.70K
John P. Butler
2 Feb 2026
CEO and President
Sold on a plan
96,065
$1.39
$133.53K
John P. Butler
2 Feb 2026
CEO and President
Sold on a plan
46,660
$1.39
$64.86K
Erik Ostrowski
2 Feb 2026
SVP, CFO, CBO & Treasurer
Sold on a plan
34,951
$1.39
$48.58K
Carolyn M. Rucci
2 Feb 2026
SVP, Chief Legal Officer
Sold on a plan
27,544
$1.39
$38.29K
Carolyn M. Rucci
2 Feb 2026
SVP, Chief Legal Officer
Sold on a plan
25,382
$1.39
$35.28K
Carolyn M. Rucci
2 Feb 2026
SVP, Chief Legal Officer
Sold on a plan
16,846
$1.39
$23.42K
Steven Keith Burke
2 Feb 2026
SVP, Chief Medical Officer
Sold on a plan
20,701
$1.39
$28.77K
Steven Keith Burke
2 Feb 2026
SVP, Chief Medical Officer
Sold on a plan
25,375
$1.39
$35.27K
Steven Keith Burke
2 Feb 2026
SVP, Chief Medical Officer
Sold on a plan
21,582
$1.39
$30.00K
Nicholas Grund
2 Feb 2026
Chief Commercial Officer
Sold on a plan
31,244
$1.39
$43.43K
Nicholas Grund
2 Feb 2026
Chief Commercial Officer
Sold on a plan
53,585
$1.39
$74.48K
Richard C Malabre
2 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
13,382
$1.39
$18.60K
Richard C Malabre
2 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
36,142
$1.39
$50.24K

What was left out

Form 4 filings counted 22
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,363,450
History held since 26 Mar 2014